Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection.
Zhao Y, Maule J, McCracken J, Li Y, Rapisardo S, Yang LH, Wang E. Zhao Y, et al. Among authors: rapisardo s. Br J Haematol. 2020 May;189(3):e64-e67. doi: 10.1111/bjh.16476. Epub 2020 Feb 28. Br J Haematol. 2020. PMID: 32108332 Free article. No abstract available.
T-lymphoblastic lymphoma and acute myeloid leukaemia transformed from myeloid neoplasm with eosinophilia: a divergent evolution of myeloid neoplasm with monosomy 7 but no detectable tyrosine kinase gene rearrangements designated by the WHO Classification.
Yang LH, Zhao Y, Maule J, Rapisardo S, Wang E. Yang LH, et al. Among authors: rapisardo s. Br J Haematol. 2020 Sep;190(5):e307-e312. doi: 10.1111/bjh.16886. Epub 2020 Jun 11. Br J Haematol. 2020. PMID: 32525559 Free article. No abstract available.
Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature.
Li Y, Maule J, Neff JL, McCall CM, Rapisardo S, Lagoo AS, Yang LH, Crawford RD, Zhao Y, Wang E. Li Y, et al. Among authors: rapisardo s. Mod Pathol. 2019 Dec;32(12):1712-1726. doi: 10.1038/s41379-019-0325-6. Epub 2019 Aug 1. Mod Pathol. 2019. PMID: 31371806 Free article. Review.
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study.
Cohen S, Wells AF, Curtis JR, Dhar R, Mellors T, Zhang L, Withers JB, Jones A, Ghiassian SD, Wang M, Connolly-Strong E, Rapisardo S, Gatalica Z, Pappas DA, Kremer JM, Saleh A, Akmaev VR. Cohen S, et al. Among authors: rapisardo s. Rheumatol Ther. 2021 Sep;8(3):1159-1176. doi: 10.1007/s40744-021-00330-y. Epub 2021 Jun 19. Rheumatol Ther. 2021. PMID: 34148193 Free PMC article.